Striving for evidence in e-health evaluation: lessons from health technology assessment.

J Telemed Telecare

Global e-Health Research and Training Program, Health Telematics Unit, University of Calgary, Canada.

Published: April 2006

Evaluation is crucial to the integration of e-health applications into the health-care system and their ultimate sustainability. However, e-health evaluation is often criticized for the poor quality of research design, the lack of common outcome indicators and the absence of an agreed theory. Health technology assessment (HTA) could offer a sound methodological basis for e-health evaluation. However, there have been major concerns about the applicability of the HTA approach to the evaluation of e-health initiatives. Evaluators -- and decision makers -- must accept that telehealth evaluation may serve different purposes for different stakeholders, and therefore concede that no single evaluation framework or methodology, even the randomized controlled trial, is totally objective. To address the complex environment of telehealth evaluation, a participatory strategy is useful, whereby stakeholders are involved in the study design and definition of evaluation questions at each phase. This will also build confidence between the evaluation team and the stakeholders, facilitating informed decision making through an integrated knowledge mobilization activity.

Download full-text PDF

Source
http://dx.doi.org/10.1258/135763305775124722DOI Listing

Publication Analysis

Top Keywords

e-health evaluation
12
evaluation
10
health technology
8
technology assessment
8
telehealth evaluation
8
e-health
5
striving evidence
4
evidence e-health
4
evaluation lessons
4
lessons health
4

Similar Publications

Technology and Dementia Preconference.

Alzheimers Dement

December 2024

School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.

Background: The success of therapeutic options for treatment of Alzheimer's disease (AD) and the growing emphasis for such treatment to commence in the pre-clinical phase makes it necessary to have robust empirical models of clinical disease progression to understand findings from clinical trials, allow clinicians to evaluate effects of new drugs, and to select individuals for future trials. Such models have been developed from relatively small samples, with incomplete data/substantial loss to follow-up. The ADOPIC consortium provides the largest complete AD natural history sample to date.

View Article and Find Full Text PDF

: Interprofessional electronic consultations (eConsults) can reduce health care utilization and improve access to specialty care. However, health care utilization and access impacts of eConsults for headache disorders remain incompletely characterized. : We conducted a retrospective, 1:3-matched cohort study comparing patients referred for in-person headache evaluations to patients who had a headache-related eConsult.

View Article and Find Full Text PDF

Digital Twins for Clinical and Operational Decision-Making: Scoping Review.

J Med Internet Res

January 2025

Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Brisbane, Australia.

Background: The health care industry must align with new digital technologies to respond to existing and new challenges. Digital twins (DTs) are an emerging technology for digital transformation and applied intelligence that is rapidly attracting attention. DTs are virtual representations of products, systems, or processes that interact bidirectionally in real time with their actual counterparts.

View Article and Find Full Text PDF

Opportunities and barriers for reimbursement of digital therapeutics in Austria: Findings From expert interviews.

Digit Health

January 2025

University Institute of Sports Medicine, Prevention and Rehabilitation, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria.

Background: Digital therapeutics (DTx) are software-based interventions that aim to prevent or treat especially non-communicable diseases. Currently, no framework for reimbursement of DTx exists in Austria. The aim of this study was to gather a comprehensive perspective on regulatory considerations of Austrian stakeholders with regard to reimbursement of DTx and to outline strategies for establishing a national reimbursement framework.

View Article and Find Full Text PDF

Importance: The ability to predict the onset of mild cognitive impairment (MCI) and Alzheimer dementia (AD) could allow older adults and clinicians to make informed decisions about dementia care.

Objective: To assess whether the age at onset of MCI and AD can be predicted using a statistical modeling approach.

Design, Setting, And Participants: This prognostic study used data from 2 aging and dementia cohort studies-the Australian Imaging, Biomarker and Lifestyle (AIBL) study and the Alzheimer's Disease Neuroimaging Initiative (ADNI)-for model development and validation of the Florey Dementia Index (FDI), a tool used to predict the age at onset of MCI and AD in older adults.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!